103 related articles for article (PubMed ID: 10436364)
1. Prognostic significance of tumor ploidy and histomorphological parameters in adenocarcinoma of Barrett's esophagus.
Böttger T; Dutkowski P; Kirkpatrick CJ; Junginger T
Dig Surg; 1999; 16(3):180-5. PubMed ID: 10436364
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of histomorphological parameters and DNA content and their therapeutic consequences in esophageal carcinoma: a multivariate approach.
Boettger T; Dutkowski P; Kirkpatrick CJ; Seifert JK; Junginger T
Hepatogastroenterology; 1998; 45(22):994-1004. PubMed ID: 9755996
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
4. DNA ploidy as a prognostic factor for patients with an adenocarcinoma in Barrett's esophagus.
Menke-Pluymers MB; Hop WC; Mulder AH; Tilanus HW
Hepatogastroenterology; 1995; 42(6):786-8. PubMed ID: 8847023
[TBL] [Abstract][Full Text] [Related]
5. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
6. [Dna ploidy in adenocarcinoma of Barrett's esophagus].
Flejou JF; Doublet B; Potet F; Metayer J; Hemet J
Ann Pathol; 1990; 10(3):161-5. PubMed ID: 2386598
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis.
von Rahden BH; Stein HJ; Feith M; Pühringer F; Theisen J; Siewert JR; Sarbia M
Mol Carcinog; 2006 Oct; 45(10):786-94. PubMed ID: 16921482
[TBL] [Abstract][Full Text] [Related]
8. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content].
Robaszkiewicz M; Volant A; Hardy E; Nousbaum JB; Calament G; Cauvin JM; Bail JP; Lozach P; Gouerou H
Gastroenterol Clin Biol; 1992; 16(6-7):540-6. PubMed ID: 1526415
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy status and proliferative activity as markers of malignant potential in Barrett's esophagus: flow cytometric study using routinely paraffin-embedded tissue.
Giménez A; Minguela A; de Haro LM; Parrilla P; Bermejo J; Pérez D; García AM; Ortiz MA; Molina J; Alvarez R
World J Surg; 2000 Jan; 24(1):72-7. PubMed ID: 10594207
[TBL] [Abstract][Full Text] [Related]
10. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
Schumpelick V; Dreuw B; Ophoff K; Fass J
Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
[TBL] [Abstract][Full Text] [Related]
11. Beta 1 integrin expression in adenocarcinoma of Barrett's esophagus.
Bottger TC; Youssef V; Dutkowski P; Seifert J; Maschek H; Brenner W; Junginger T
Hepatogastroenterology; 1999; 46(26):938-43. PubMed ID: 10370643
[TBL] [Abstract][Full Text] [Related]
12. Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy.
Dunn JM; Mackenzie GD; Oukrif D; Mosse CA; Banks MR; Thorpe S; Sasieni P; Bown SG; Novelli MR; Rabinovitch PS; Lovat LB
Br J Cancer; 2010 May; 102(11):1608-17. PubMed ID: 20461081
[TBL] [Abstract][Full Text] [Related]
13. Role of DNA content determination by image analysis in confirmation of dysplasia in Barrett's esophagus.
Khan M; Bui HX; del Rosario A; Abdulla M; Ballouk F; Sim YJ; Ross JS
Mod Pathol; 1994 Feb; 7(2):169-74. PubMed ID: 8008738
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of p53 tumor suppressor gene mutations in adenocarcinoma in Barrett esophagus].
Schneider PM; Hölscher AH; Wegerer S; König U; Becker K; Siewert JR
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):495-9. PubMed ID: 14518305
[TBL] [Abstract][Full Text] [Related]
15. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
16. High-fidelity DNA histograms in neoplastic progression in Barrett's esophagus.
Yu C; Zhang X; Huang Q; Klein M; Goyal RK
Lab Invest; 2007 May; 87(5):466-72. PubMed ID: 17310216
[TBL] [Abstract][Full Text] [Related]
17. Progression to cancer in Barrett's esophagus is associated with genomic instability.
Rabinovitch PS; Reid BJ; Haggitt RC; Norwood TH; Rubin CE
Lab Invest; 1989 Jan; 60(1):65-71. PubMed ID: 2911184
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of 108 cases with adenocarcinoma Barretts's esophagus].
Han JQ; Liu Q; Liang RX; Qu FS; Yan TX; Sun YH; Li XQ
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):470-3. PubMed ID: 17974287
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
20. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.
Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H
Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]